Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing

PHILADELPHIA, Oct. 16, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 29, 2025 (the "Class Period").

Investor Deadline: Investors who purchased MoonLake securities during the Class Period may, no later than December 15, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE .

MoonLake is a clinical-stage biotechnology company headquartered in Zug, Switzerland.

According to the lawsuit, MoonLake and certain executives made false and misleading statements regarding the Company's only drug candidate, sonelokimab (SLK), in testing as a treatment for certain skin conditions. The complaint alleges that the Company repeatedly promoted SLK's Nanobody structure as providing superior clinical advantages over traditional monoclonal antibodies, such as FDA-approved BIMZELX.

On September 28, 2025, the Company announced Phase 3 clinical trial results for SLK, which, according to the lawsuit, showed that SLK failed to achieve efficacy comparable to BIMZELX. Analysts reportedly described the data as a "disastrous result," and MoonLake's stock declined nearly 90%, or $55.75 per share, in a single trading session.

If you are a MoonLake investor and would like to learn more about this action, CLICK HERE  or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865.

About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

For more information or to discuss your rights, please contact:
Andrew Abramowitz
Senior Counsel
Berger Montague
(215) 875-3015
[email protected]

Caitlin Adorni
Director of Portfolio & Institutional Client Monitoring Services
Berger Montague
(267) 764-4865
[email protected] 

SOURCE Berger Montague